What Is Sepsis? The Life-Threatening Response to Infection

Defining Sepsis: From SIRS to Sepsis-3

Sepsis is a medical emergency resulting from the body's extreme and dysregulated response to an infection, causing damage to its own tissues and organs. The clinical understanding of sepsis has evolved significantly over the past three decades. The original 1992 consensus definition introduced the concept of Systemic Inflammatory Response Syndrome (SIRS)—a clinical pattern defined by two or more of: temperature above 38°C or below 36°C; heart rate above 90 beats/min; respiratory rate above 20 breaths/min or PaCO2 below 32 mmHg; and white blood cell count above 12,000/mm3, below 4,000/mm3, or over 10% immature bands. Sepsis was then defined as SIRS occurring in response to a suspected infection.

The Sepsis-3 definitions, published in 2016, replaced the SIRS framework. Recognizing that SIRS criteria are too non-specific (present in millions of non-septic patients) and that the emphasis should be on organ dysfunction, Sepsis-3 defines sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection, identified clinically by an acute change in SOFA (Sequential [Sepsis-related] Organ Failure Assessment) score of 2 or more points. Septic shock—the most severe form—is defined as sepsis plus circulatory, cellular, and metabolic abnormalities profound enough to substantially increase mortality: requiring vasopressors to maintain a mean arterial pressure (MAP) of 65 mmHg or above, and having a serum lactate above 2 mmol/L despite adequate fluid resuscitation. The in-hospital mortality of septic shock exceeds 40%.

The Pathophysiology: How Infection Becomes Organ Failure

Sepsis begins with an infection—bacterial (the most common), viral, fungal, or parasitic. The immune system detects pathogen-associated molecular patterns (PAMPs)—molecules characteristic of microorganisms (such as lipopolysaccharide from gram-negative bacteria)—through pattern recognition receptors including Toll-like receptors. This triggers an inflammatory cascade in which immune cells release massive quantities of pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6, IL-8) intended to contain and eliminate the infection.

In sepsis, this response becomes dysregulated—simultaneous pro-inflammatory and anti-inflammatory responses occur in a chaotic pattern that damages the host rather than just the pathogen. Endothelial cells (lining blood vessels throughout the body) become activated and damaged, leading to increased vascular permeability (causing fluid to leak into tissues, producing edema and reducing circulating blood volume), loss of vascular tone (vasodilation causing blood pressure to fall), and activation of the coagulation cascade. Disseminated intravascular coagulation (DIC)—simultaneous clot formation throughout the microvasculature and consumption of clotting factors leading to paradoxical bleeding—occurs in severe sepsis. As oxygen delivery to tissues fails due to circulatory collapse, cells switch to anaerobic metabolism, producing lactic acid (reflected in elevated serum lactate) and eventually losing the ability to maintain cellular homeostasis, leading to multi-organ failure.

Common Sources of Infection and High-Risk Groups

The lungs (pneumonia) are the most common source of infection in sepsis, followed by the abdomen (appendicitis, peritonitis, bowel perforation, cholangitis), the urinary tract (pyelonephritis, urosepsis), the bloodstream (bacteremia, endocarditis), and skin and soft tissues (cellulitis, necrotizing fasciitis). In a significant proportion of cases (30–50%), no source is identified despite extensive investigation—termed sepsis of unknown origin.

Those at greatest risk of developing sepsis include: the elderly (the majority of sepsis deaths occur in those over 65, who have reduced immune reserve and multiple comorbidities); newborns and infants (neonatal sepsis has a high mortality); immunocompromised patients (cancer patients on chemotherapy, transplant recipients on immunosuppression, HIV patients); patients with indwelling medical devices (intravenous catheters, urinary catheters, mechanical ventilators); and those with chronic conditions such as diabetes, chronic kidney disease, or cirrhosis. Community-acquired sepsis often begins as a seemingly straightforward respiratory or urinary infection that is not recognized early enough.

Diagnosis: Recognizing Sepsis Early

Early recognition of sepsis is critical to improving outcomes. The clinical presentation is heterogeneous—patients may present with fever, chills, altered mental status, rapid breathing, low blood pressure, and a general appearance of being very unwell. However, sepsis can also present atypically, particularly in the elderly and immunocompromised, who may show hypothermia (low body temperature), normal or low white blood cell counts, or simply confusion and weakness without obvious fever.

Diagnostic workup includes blood cultures (taken before antibiotic administration whenever possible), complete blood count, metabolic panel, lactate level, coagulation studies, C-reactive protein, procalcitonin (a biomarker elevated in bacterial infection), blood gas analysis, and imaging to identify the source of infection. The bedside qSOFA (quick SOFA) score—respiratory rate ≥22/min, altered mentation, and systolic BP ≤100 mmHg—identifies adult patients with suspected infection who are at greater risk of poor outcomes and may prompt more intensive investigation and management. Lactate levels above 2 mmol/L indicate tissue hypoperfusion even in the absence of hypotension (cryptic shock), significantly worsening prognosis.

Treatment: Time-Critical Antibiotics and Supportive Care

Treatment of sepsis is a medical emergency requiring prompt, simultaneous action on multiple fronts. The Surviving Sepsis Campaign (SSC) bundles—evidence-based packages of interventions—emphasize that for every hour of delay in appropriate antibiotic administration in septic shock, mortality increases by approximately 7%. Current SSC guidelines recommend administering appropriate broad-spectrum intravenous antibiotics within one hour of sepsis recognition, obtaining blood cultures before antibiotics if this can be done without significant delay, and administering 30 mL/kg of intravenous crystalloid fluid (typically within the first three hours) for fluid resuscitation in hypotensive patients or those with elevated lactate.

When fluid resuscitation is insufficient to restore blood pressure, vasopressors—particularly norepinephrine (noradrenaline) as first-line—are administered to maintain MAP above 65 mmHg. In refractory septic shock, vasopressin, hydrocortisone, and inotropes (for cardiac dysfunction) may be added. Organ-supportive therapies include mechanical ventilation for respiratory failure (using lung-protective ventilation strategies), renal replacement therapy for acute kidney injury, and transfusion for severe anemia. Antibiotic therapy should be de-escalated—narrowed from broad-spectrum to targeted agents—as soon as culture and sensitivity results are available, to minimize antibiotic resistance. Despite decades of research, no immunomodulatory therapy has yet demonstrated a consistent mortality benefit across unselected sepsis patients, underscoring the challenge of treating a condition defined by immunological heterogeneity.